ECSP099065A - Derivados de cinamoil-piperazina y su utilización como antagonistas de par-1 - Google Patents
Derivados de cinamoil-piperazina y su utilización como antagonistas de par-1Info
- Publication number
- ECSP099065A ECSP099065A EC2009009065A ECSP099065A ECSP099065A EC SP099065 A ECSP099065 A EC SP099065A EC 2009009065 A EC2009009065 A EC 2009009065A EC SP099065 A ECSP099065 A EC SP099065A EC SP099065 A ECSP099065 A EC SP099065A
- Authority
- EC
- Ecuador
- Prior art keywords
- par
- cinamoil
- piperazina
- antagonist
- derivatives
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 101710121440 Proteinase-activated receptor 1 Proteins 0.000 title 1
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 title 1
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical group 0.000 abstract 3
- 102000032626 PAR-1 Receptor Human genes 0.000 abstract 2
- 108010070519 PAR-1 Receptor Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0605419A FR2902426B1 (fr) | 2006-06-19 | 2006-06-19 | Derives de cinnamoyl-piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP099065A true ECSP099065A (es) | 2009-02-27 |
Family
ID=37846050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2009009065A ECSP099065A (es) | 2006-06-19 | 2009-01-13 | Derivados de cinamoil-piperazina y su utilización como antagonistas de par-1 |
Country Status (31)
| Country | Link |
|---|---|
| US (2) | US8217046B2 (enExample) |
| EP (1) | EP2041104B1 (enExample) |
| JP (1) | JP5356222B2 (enExample) |
| KR (1) | KR101468752B1 (enExample) |
| CN (1) | CN101472907B (enExample) |
| AR (1) | AR061520A1 (enExample) |
| AT (1) | ATE478059T1 (enExample) |
| AU (1) | AU2007263051B2 (enExample) |
| BR (1) | BRPI0713132B8 (enExample) |
| CA (1) | CA2655527C (enExample) |
| CR (1) | CR10509A (enExample) |
| DE (1) | DE602007008572D1 (enExample) |
| EC (1) | ECSP099065A (enExample) |
| ES (1) | ES2349324T3 (enExample) |
| FR (1) | FR2902426B1 (enExample) |
| GE (1) | GEP20115201B (enExample) |
| IL (1) | IL195972A (enExample) |
| MA (1) | MA30756B1 (enExample) |
| MX (1) | MX2008016447A (enExample) |
| MY (1) | MY144461A (enExample) |
| NO (1) | NO341389B1 (enExample) |
| NZ (1) | NZ573764A (enExample) |
| PL (1) | PL2041104T3 (enExample) |
| PT (1) | PT2041104E (enExample) |
| RU (1) | RU2440997C2 (enExample) |
| SA (1) | SA07280330B1 (enExample) |
| TN (1) | TNSN08522A1 (enExample) |
| TW (1) | TWI404710B (enExample) |
| UA (1) | UA96947C2 (enExample) |
| WO (1) | WO2007147824A1 (enExample) |
| ZA (1) | ZA200900303B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3014693B1 (fr) | 2013-12-16 | 2016-01-08 | Pf Medicament | Utilisation de la 3-(2-chloro-phenyl)-1-[4-(4-fluoro-benzyl)-piperazin-1-yl]-propenone pour la prevention et/ou le traitement des pathologies fonctionnelles pelvi-perineales |
| EP3143036B1 (en) | 2014-05-11 | 2023-08-02 | Tel Hashomer Medical Research Infrastructure and Services Ltd. | Par-1 based therapeutic conjugates and uses thereof |
| WO2016066789A1 (fr) * | 2014-10-31 | 2016-05-06 | Pierre Fabre Medicament | Utilisation d'antagonistes par-1 pour la prevention et/ou le traitement des pathologies fonctionnelles pelvi-perineales |
| CN104496922B (zh) * | 2015-01-13 | 2016-04-06 | 佛山市赛维斯医药科技有限公司 | 腈基苯二烯四氮唑类化合物、其制备方法和用途 |
| CN104496924B (zh) * | 2015-01-13 | 2016-04-13 | 佛山市赛维斯医药科技有限公司 | 卤苯二烯四氮唑类化合物、其制备方法和用途 |
| CN104529860B (zh) * | 2015-01-13 | 2016-06-01 | 佛山市赛维斯医药科技有限公司 | 一种含硝基苯和二烯氟代金刚烷结构的化合物及制备方法 |
| CN104496879A (zh) * | 2015-01-13 | 2015-04-08 | 佛山市赛维斯医药科技有限公司 | 一种含腈基苯和二烯氟代金刚烷结构的化合物和用途 |
| CN105949116A (zh) * | 2016-06-08 | 2016-09-21 | 青岛理工大学 | 酰基哌嗪类化合物及其制备方法和用途 |
| EP3278802A1 (en) | 2016-08-04 | 2018-02-07 | Metabolys | New treatment for the non alcoholic steatohepatitis and fibrosis |
| RU2662308C1 (ru) * | 2017-12-25 | 2018-07-25 | Феркат Адельзянович Халиуллин | Средство для лечения и профилактики тромбоза |
| IL278311B2 (en) | 2018-05-02 | 2024-02-01 | Tel Hashomer Medical Res Infrastructure & Services Ltd | Preparations and methods for the treatment of glioblastoma |
| FR3090317B1 (fr) | 2018-12-19 | 2021-05-07 | Cvasthera | Utilisation d’un antagoniste de par-1 pour le traitement d’une maladie inflammatoire chronique intestinale |
| KR102791326B1 (ko) * | 2021-09-29 | 2025-04-04 | 주성수 | 피페론구민계 화합물을 유효성분으로 포함하는 혈관질환 예방 또는 치료용 약학적 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61106564A (ja) * | 1984-10-30 | 1986-05-24 | Terumo Corp | 不飽和脂肪酸アミド誘導体およびこれを含有する血小板凝集抑制剤 |
| JPS6219577A (ja) * | 1985-07-16 | 1987-01-28 | Kanebo Ltd | 新規なベンジルピペラジン誘導体および該化合物を有効成分とする医薬組成物 |
| SE9201956D0 (sv) * | 1992-06-25 | 1992-06-25 | Kabi Pharmacia Ab | Novel nicotinicacid esters |
| US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
| WO2002076965A1 (en) * | 2001-03-23 | 2002-10-03 | John Matsoukas | Non peptide mimetics based on the active sequence s42fllr46 of the thrombin receptor for the treatment of thrombosis and cancer |
| GB0224917D0 (en) * | 2002-10-25 | 2002-12-04 | Novartis Ag | Organic compounds |
| CA2504735C (en) * | 2002-11-07 | 2009-06-23 | Merck & Co., Inc. | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| CN1775762A (zh) * | 2005-12-06 | 2006-05-24 | 山东大学 | 川芎嗪酰基哌嗪衍生物、制备方法和药物组合物与应用 |
| FR2917622B1 (fr) * | 2007-06-19 | 2009-10-23 | Pierre Fabre Medicament Sa | Utilisation d'un antagoniste par1 dans le traitement de la fibrillation atriale. |
-
2006
- 2006-06-19 FR FR0605419A patent/FR2902426B1/fr not_active Expired - Fee Related
-
2007
- 2007-06-19 MX MX2008016447A patent/MX2008016447A/es active IP Right Grant
- 2007-06-19 DE DE602007008572T patent/DE602007008572D1/de active Active
- 2007-06-19 AU AU2007263051A patent/AU2007263051B2/en not_active Ceased
- 2007-06-19 EP EP07786761A patent/EP2041104B1/en active Active
- 2007-06-19 CA CA2655527A patent/CA2655527C/en not_active Expired - Fee Related
- 2007-06-19 GE GEAP200711058A patent/GEP20115201B/en unknown
- 2007-06-19 BR BRPI0713132A patent/BRPI0713132B8/pt not_active IP Right Cessation
- 2007-06-19 UA UAA200900373A patent/UA96947C2/ru unknown
- 2007-06-19 US US12/305,584 patent/US8217046B2/en not_active Expired - Fee Related
- 2007-06-19 SA SA07280330A patent/SA07280330B1/ar unknown
- 2007-06-19 AT AT07786761T patent/ATE478059T1/de not_active IP Right Cessation
- 2007-06-19 PL PL07786761T patent/PL2041104T3/pl unknown
- 2007-06-19 PT PT07786761T patent/PT2041104E/pt unknown
- 2007-06-19 AR ARP070102685A patent/AR061520A1/es active IP Right Grant
- 2007-06-19 ES ES07786761T patent/ES2349324T3/es active Active
- 2007-06-19 NZ NZ573764A patent/NZ573764A/en not_active IP Right Cessation
- 2007-06-19 JP JP2009515860A patent/JP5356222B2/ja not_active Expired - Fee Related
- 2007-06-19 CN CN200780022674XA patent/CN101472907B/zh not_active Expired - Fee Related
- 2007-06-19 KR KR1020097000946A patent/KR101468752B1/ko not_active Expired - Fee Related
- 2007-06-19 WO PCT/EP2007/056086 patent/WO2007147824A1/en not_active Ceased
- 2007-06-19 RU RU2008152247/04A patent/RU2440997C2/ru active
- 2007-06-19 MY MYPI20085203A patent/MY144461A/en unknown
- 2007-06-20 TW TW096122073A patent/TWI404710B/zh not_active IP Right Cessation
-
2008
- 2008-12-16 TN TNP2008000522A patent/TNSN08522A1/en unknown
- 2008-12-16 CR CR10509A patent/CR10509A/es unknown
- 2008-12-16 IL IL195972A patent/IL195972A/en active IP Right Grant
-
2009
- 2009-01-09 MA MA31560A patent/MA30756B1/fr unknown
- 2009-01-13 EC EC2009009065A patent/ECSP099065A/es unknown
- 2009-01-14 ZA ZA2009/00303A patent/ZA200900303B/en unknown
- 2009-01-16 NO NO20090270A patent/NO341389B1/no not_active IP Right Cessation
-
2012
- 2012-05-21 US US13/476,487 patent/US8513258B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP099065A (es) | Derivados de cinamoil-piperazina y su utilización como antagonistas de par-1 | |
| AR072016A1 (es) | Derivados de isoxazol que funcionan como potenciadores de los receptores de glutamato | |
| PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
| PE20071321A1 (es) | Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados | |
| PE20110547A1 (es) | Compuestos de isoindolina con actividad anticancerigena | |
| PE20141371A1 (es) | Compuestos heterociclicos y usos de los mismos | |
| MX2013006847A (es) | Compuesto heterociclico fusionado y su uso para el control de plagas. | |
| PE20141404A1 (es) | Derivados de tieno[3,2-d]pirimidina que tienen actividad inhibidora por las quinasas de las proteinas | |
| DK2134691T3 (da) | Quinolinonderivativer som parp- og tank-inhibitorer | |
| AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
| CR20120510A (es) | Derivados de piperidin-4-il azetidina como inhibidores de jak1 | |
| ECSP088358A (es) | Tratamiento y profilaxis de microangiopatías | |
| CR20130338A (es) | Compuestos heterocíclicos nitrogenados sustituidos fusionados en posición 6,6 y usos de los mismos | |
| CU20090070A7 (es) | Nuevos derivados de sulfonamida como antagonistas de la bradiquinina | |
| CR9590A (es) | Derivados de n-(heteroaril)-1-heteroarilalquil-1h-indol-2-carboxamida su prepracion y su aplicacion en terapeutica | |
| PA8776401A1 (es) | Nuevos compuestos hetericiclicos nitrogenados, su preparación y su utilización como medicamentos antibacterianos | |
| ECSP088527A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
| UY27774A1 (es) | Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona | |
| CY1113911T1 (el) | Παραγωγα sf5 ως αναστολεις par1, η παρασκευη τους και η χρηση τους ως φαρμακα | |
| ECSP088194A (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, así como su uso como medicamentos | |
| CO6150147A2 (es) | Derivados de 5,6-bisaril-2-piridin-carboxamida su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii | |
| UY33049A (es) | Derivados de piridino-piridinonas, su preparación y su aplicación en terapéutica | |
| GT200500292A (es) | Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
| AR077094A1 (es) | Derivados de pirazinooxazepina, composiciones farmaceuticas y su uso en el tratamiento de un sintoma del aparato urinario inferior, obesidad y/o prolapso de organos | |
| ECSP088761A (es) | Nuevas combinaciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos |